UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort

Scientific reports, 2016-10, Vol.6 (1), p.34823-34823, Article 34823

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a prognostic model of resectable small-cell lung cancer: a large population-based cohort study and external validation

Journal of translational medicine, 2020-06, Vol.18 (1), p.237-237, Article 237

2020

Link zum Volltext

Verfügbarkeit prüfen

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial-mesenchymal Transition

Scientific reports, 2019-02, Vol.9 (1), p.1324-1324, Article 1324

2019

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysis

Oncotarget, 2016-11, Vol.7 (45), p.74350-74361

2016

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral neutrophil granulocytes contribute to epithelial-mesenchymal transition in lung adenocarcinoma cells

Tumor biology, 2015-09, Vol.36 (10), p.7789-7796

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC

Scientific reports, 2017-04, Vol.7 (1), p.584-584, Article 584

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma

PeerJ (San Francisco, CA), 2021-10, Vol.9, p.e12275-e12275, Article e12275

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence and prognostic nomogram for resected non-small cell neuroendocrine tumor: A population-based respective study in China and the SEER database

Heliyon, 2023-04, Vol.9 (4), p.e15319-e15319, Article e15319

2023

Link zum Volltext

Verfügbarkeit prüfen

SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment

Heliyon, 2022-10, Vol.8 (10), p.e10866-e10866, Article e10866

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction

Tumor biology, 2015-04, Vol.36 (4), p.2965-2971

2015

Link zum Volltext

Verfügbarkeit prüfen

Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma

Genomics (San Diego, Calif.), 2021-01, Vol.113 (1), p.291-304

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.94-102

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma

Chemico-biological interactions, 2024-01, Vol.387, p.110794-110794, Article 110794

2024

Link zum Volltext

Verfügbarkeit prüfen

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy

Oncotarget, 2017-04, Vol.8 (17), p.29501-29518

2017

Link zum Volltext

Verfügbarkeit prüfen

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Aging (Albany, NY.), 2024-05, Vol.16 (10), p.8772-8809

2024

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database

Gene, 2017-09, Vol.630, p.49-58

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival nomogram for patients with initially diagnosed metastatic non-small-cell lung cancer: a SEER-based study

Future oncology (London, England), 2019-10, Vol.15 (29), p.3395-3409

2019

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model

International immunopharmacology, 2020-09, Vol.86, p.106744-106744, Article 106744

2020

Link zum Volltext

Verfügbarkeit prüfen

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma

Medicine (Baltimore), 2017-11, Vol.96 (45), p.e8450-e8450

2017

Link zum Volltext

Verfügbarkeit prüfen

Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer

Scientific reports, 2017-10, Vol.7 (1), p.13050-10, Article 13050

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer

Journal of Cancer, 2018-01, Vol.9 (8), p.1421-1429

2018

Link zum Volltext

Verfügbarkeit prüfen

PKD1 is downregulated in non-small cell lung cancer and mediates the feedback inhibition of mTORC1-S6K1 axis in response to phorbol ester

The international journal of biochemistry & cell biology, 2015-03, Vol.60, p.34-42

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis

Journal of thoracic disease, 2017-10, Vol.9 (10), p.4046-4056

2017

Link zum Volltext

Verfügbarkeit prüfen

Expressions of insulin-like growth factor receptor-1 and cezanne-1 in lung adenocarcinoma

Medical oncology (Northwood, London, England), 2017-05, Vol.34 (5), p.78-78, Article 78

2017

Link zum Volltext

Verfügbarkeit prüfen

Cezanne contributes to cancer progression by playing a key role in the deubiquitination of IGF-1R

American journal of cancer research, 2020-01, Vol.10 (12), p.4342-4356

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort

Development and validation of a prognostic model of resectable small-cell lung cancer: a large population-based cohort study and external validation

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial-mesenchymal Transition

The efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysis

Intratumoral neutrophil granulocytes contribute to epithelial-mesenchymal transition in lung adenocarcinoma cells

Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC

Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma

Incidence and prognostic nomogram for resected non-small cell neuroendocrine tumor: A population-based respective study in China and the SEER database

SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment

Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction

Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma

The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database

Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database

Survival nomogram for patients with initially diagnosed metastatic non-small-cell lung cancer: a SEER-based study

Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma

Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer

Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer

PKD1 is downregulated in non-small cell lung cancer and mediates the feedback inhibition of mTORC1-S6K1 axis in response to phorbol ester

Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis

Expressions of insulin-like growth factor receptor-1 and cezanne-1 in lung adenocarcinoma

Cezanne contributes to cancer progression by playing a key role in the deubiquitination of IGF-1R

Suchergebnisse filtern